| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 111.18M | 165.14M | 84.39M | -64.09M | -6.62M | -5.36M |
| Gross Profit | 111.18M | 165.14M | 84.39M | -64.09M | -6.67M | -5.37M |
| EBITDA | 6.40M | 152.08M | 71.68M | 45.66M | -136.31M | -19.10M |
| Net Income | 19.35M | 106.82M | 50.93M | 32.73M | -94.84M | -12.46M |
Balance Sheet | ||||||
| Total Assets | 836.83M | 857.95M | 730.51M | 681.35M | 647.09M | 987.05M |
| Cash, Cash Equivalents and Short-Term Investments | 781.93M | 36.01M | 619.48M | 539.20M | 309.58M | 123.59M |
| Total Debt | 0.00 | 0.00 | 6.99M | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 67.78M | 71.25M | 33.10M | 5.83M | 5.96M | 101.05M |
| Stockholders Equity | 769.05M | 786.70M | 697.41M | 675.52M | 641.13M | 886.00M |
Cash Flow | ||||||
| Free Cash Flow | -12.52M | -2.55M | -3.30M | 7.60M | -94.84M | -56.91M |
| Operating Cash Flow | -12.52M | -2.55M | -3.30M | 7.60M | -94.84M | -56.91M |
| Investing Cash Flow | 40.68M | 4.32M | 42.57M | -43.86M | 73.57M | 161.32M |
| Financing Cash Flow | -38.93M | -35.49M | -31.57M | -28.56M | -25.28M | -22.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | AU$68.59M | 7.05 | 32.22% | 6.39% | 22.67% | 19.47% | |
69 Neutral | ― | 34.32 | 14.39% | 5.33% | 175.90% | 109.57% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | AU$63.06M | -40.11 | 3.57% | 6.89% | 30.36% | -31.47% | |
55 Neutral | AU$26.98M | 70.25 | 2.17% | 2.94% | 38.32% | ― | |
53 Neutral | AU$28.88M | 29.10 | 2.42% | 2.03% | 18.17% | ― |
Hearts and Minds Investments reported a modest portfolio gain of 0.21% in January, outperforming the MSCI World Accumulation Index (AUD), which fell 2.14%, and maintaining an annualised pre-tax return of 10.68% since its 2018 inception. The company’s shares traded at $3.14 with pre-tax NTA of $3.61 and a fully franked annualised dividend yield of about 5.7%, supported by a latest final dividend of 9.0 cents per share.
Recent performance was driven by strong contributions from the 2025 Conference portfolio, notably ACM Research, up 75% since purchase, and Brookdale Senior Living, up 63% since November, while new core manager Prusik Investment Management also outperformed, aided by gains in Hong Kong names AIA, Swire Pacific, and CK Hutchison. The update underscores HM1’s ability to generate competitive returns while continuing to fund medical research, reinforcing its differentiated position in the listed investment company market for investors seeking both performance and social impact.
The most recent analyst rating on (AU:HM1) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Hearts and Minds Investments Ltd stock, see the AU:HM1 Stock Forecast page.
Hearts and Minds Investments Limited reported its estimated net tangible asset (NTA) backing per share as at 6 February 2026, indicating a pre-tax NTA of $3.53, post current tax NTA of $3.43 and post tax NTA of $3.31. These figures represent a modest decline from the prior week’s levels, signaling a slight softening in portfolio value that may be of interest to investors tracking short-term movements in the company’s underlying asset base.
The week-on-week fall in NTA suggests recent market conditions or portfolio performance have had a negative impact on the company’s asset values, although the update remains unaudited and indicative. Regular disclosure of NTA metrics underscores the firm’s commitment to transparency and provides shareholders with a timely gauge of performance, aiding investment decisions in a volatile market environment.
The most recent analyst rating on (AU:HM1) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Hearts and Minds Investments Ltd stock, see the AU:HM1 Stock Forecast page.
Hearts and Minds Investments Limited reported a modest decline in its net tangible asset (NTA) backing per share as at 30 January 2026 compared with the prior week. The pre-tax NTA fell to $3.61 from $3.68, post current tax NTA slipped to $3.52 from $3.59, and post-tax NTA eased to $3.36 from $3.41, signalling a slight softening in portfolio value that shareholders and market watchers will monitor for indications of short-term performance trends in the underlying investment portfolio.
The most recent analyst rating on (AU:HM1) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Hearts and Minds Investments Ltd stock, see the AU:HM1 Stock Forecast page.
Hearts and Minds Investments Limited has reported a slight decline in its net tangible asset (NTA) backing per share for the week ended 23 January 2026, with pre‑tax NTA falling to $3.68 from $3.75, post‑current tax NTA easing to $3.59 from $3.66, and post‑tax NTA decreasing to $3.41 from $3.46. The updated NTA figures, which are unaudited and indicative, provide investors with a timely snapshot of the company’s portfolio valuation and may signal modest short‑term softening in underlying asset values, a key metric for assessing performance and sentiment toward the listed investment vehicle.
The most recent analyst rating on (AU:HM1) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Hearts and Minds Investments Ltd stock, see the AU:HM1 Stock Forecast page.
Hearts and Minds Investments Limited has reported an unaudited estimated net tangible asset (NTA) backing per share as at 16 January 2026, with pre-tax NTA of $3.75, post current tax NTA of $3.66, and post-tax NTA of $3.46, broadly unchanged from the prior week. The largely stable NTA levels indicate that the company’s investment portfolio value and tax-adjusted position have remained steady over the period, signalling a relatively flat short-term performance environment for shareholders.
The most recent analyst rating on (AU:HM1) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Hearts and Minds Investments Ltd stock, see the AU:HM1 Stock Forecast page.
Hearts and Minds Investments reported a revised December 2025 monthly update after correcting its stated investment performance figures, confirming an annualised pre-tax return of 10.78% since its 2018 inception and a fully franked annualised dividend yield of 5.64% at 31 December, with pre-tax NTA at $3.60, post-tax NTA at $3.36 and the share price at $3.19. The portfolio fell 1.8% in December, underperforming the MSCI World Accumulation Index (AUD), while the 2025 Conference portfolio started strongly, led by ACM Research, and core manager Magellan Investment Partners added new European holdings SAP and adidas, signalling ongoing refinement of the global equity mix and reinforcing the strategy of combining shareholder returns with growing medical research funding.
The most recent analyst rating on (AU:HM1) stock is a Hold with a A$3.50 price target. To see the full list of analyst forecasts on Hearts and Minds Investments Ltd stock, see the AU:HM1 Stock Forecast page.
Hearts and Minds Investments Limited reported a 2.8% portfolio decline in December 2025, underperforming the MSCI World Accumulation Index (AUD), which fell 1.0% over the month, though since its 2018 inception the company has delivered an annualised pre-tax investment return of 10.64% and a fully franked annualised dividend yield of 5.64%. The update highlighted a strong early contribution from the 2025 Conference portfolio, particularly ACM Research, which rose 18% in December and more than 50% since purchase into early January 2026, while core manager Magellan Investment Partners added new positions in German-listed SAP and adidas, signalling continued conviction in global growth names even as the fund maintains a modest 5% cash weighting and lifts its cumulative medical research funding to $83.7 million.
The most recent analyst rating on (AU:HM1) stock is a Hold with a A$3.50 price target. To see the full list of analyst forecasts on Hearts and Minds Investments Ltd stock, see the AU:HM1 Stock Forecast page.
Hearts and Minds Investments Limited reported an increase in its net tangible asset (NTA) backing per share as at 9 January 2026, with pre‑tax NTA rising to $3.74 from $3.63 a week earlier, post current tax NTA increasing to $3.65 from $3.53, and post‑tax NTA improving to $3.46 from $3.38. The uplift in all three NTA measures indicates a positive recent performance of the company’s investment portfolio, signalling strengthened asset backing for shareholders and potentially enhancing the company’s appeal in the listed investment company sector.
The most recent analyst rating on (AU:HM1) stock is a Hold with a A$3.50 price target. To see the full list of analyst forecasts on Hearts and Minds Investments Ltd stock, see the AU:HM1 Stock Forecast page.
Hearts and Minds Investments Limited has reported its unaudited net tangible asset (NTA) backing per share as at 2 January 2026, showing a steady position over the previous week. The company’s pre-tax NTA remained unchanged at $3.63 per share, while post current tax NTA dipped slightly to $3.53 from $3.54 and post tax NTA was steady at $3.38, indicating broadly stable portfolio valuations and tax provisions over the period, with no material shifts in its underlying asset base signalled for investors.
The most recent analyst rating on (AU:HM1) stock is a Hold with a A$3.50 price target. To see the full list of analyst forecasts on Hearts and Minds Investments Ltd stock, see the AU:HM1 Stock Forecast page.
Hearts and Minds Investments Limited reported its estimated net tangible asset (NTA) backing per share as at 26 December 2025, showing a slight decline in pre-tax NTA to $3.63 from $3.64 a week earlier, while post current tax NTA remained steady at $3.54 and post tax NTA was unchanged at $3.38. The largely stable NTA levels indicate that the company’s portfolio value has been broadly steady over the period, suggesting limited short-term volatility for shareholders and offering investors a current snapshot of underlying asset backing as the year ends.
Hearts and Minds Investments Limited reported a modest increase in its net tangible asset (NTA) backing per share as at 19 December 2025, with pre-tax NTA rising to $3.64 from $3.62 a week earlier, post current tax NTA edging up to $3.54 from $3.52, and post-tax NTA moving to $3.38 from $3.37. The incremental gains across all NTA measures indicate a slight improvement in portfolio performance over the period, providing investors with a positive, albeit small, uplift in the value of their holdings heading into year-end.
Hearts and Minds Investments Ltd reported a challenging month in November 2025, with its portfolio down 5.7%, underperforming the MSCI World Accumulation Index. The portfolio’s performance was negatively impacted by the write-down of Corporate Travel Management shares, which have been suspended from trading. Despite these setbacks, the company maintains a strong annualized pre-tax investment return of 11.21% since inception and continues to support medical research through its unique investment model.
Hearts and Minds Investments Limited reported its Net Tangible Asset (NTA) backing per share as of December 5, 2025. The pre-tax NTA decreased from $3.71 to $3.63, while the post-current tax NTA fell from $3.59 to $3.53, and the post-tax NTA dropped from $3.41 to $3.38. The company has taken a conservative approach by valuing its suspended shares in Corporate Travel Management at zero, which could positively impact the pre-tax NTA by 9 cents per share if trading resumes at the previous halt price.
Hearts and Minds Investments Limited has announced an amendment to its Securities Trading & Insider Trading Policy, effective immediately. This policy update impacts directors, executives, and other designated individuals, emphasizing compliance with legal prohibitions against insider trading and adherence to internal trading procedures, which could influence the company’s governance and stakeholder trust.
Hearts and Minds Investments Limited announced its Net Tangible Asset (NTA) backing per share as of November 28, 2025, with pre-tax NTA at $3.71, post-current tax NTA at $3.59, and post-tax NTA at $3.41. The company holds 1,251,663 shares in Corporate Travel Management, which has been suspended from trading since August 2025. In the absence of a market price, the company has conservatively valued this holding at zero but anticipates potential value realization if trading resumes, potentially impacting pre-tax NTA positively by 9 cents per share.
Hearts and Minds Investments Ltd announced the results of its 2025 Annual General Meeting, where all resolutions were passed. Notably, the company faced a first strike against its Remuneration Report, primarily due to a negative vote from a US-based activist shareholder. Despite this, the board highlighted that their non-executive directors serve without remuneration, and executives work part-time at below-market rates, reflecting the company’s commitment to maintaining low operational costs.
Hearts and Minds Investments Ltd announced a change in its company secretary, with Ms. Eryl Baron resigning and Ms. Natalie Climo taking over the role. This change is significant as Ms. Climo will be responsible for communication with the ASX regarding Listing Rules Matters, potentially impacting the company’s regulatory interactions and compliance processes.
At the 2025 Annual General Meeting, Hearts and Minds Investments Limited reported a robust investment performance with a 25.5% return for the year ending June 30, 2025, driven by gains in companies like Tencent Music, Coeur Mining, and Airbus. The company’s investment performance continued to improve post-financial year, achieving a 22.6% increase by October 31, 2025, with an annualized performance of 12.3% since inception, highlighting its strong market positioning and commitment to supporting medical research.
Hearts and Minds Investments Limited has announced a refresh of its Conference Portfolio, which makes up 35% of its total investment portfolio. The portfolio includes stocks pitched at the recent Sohn Hearts & Minds Investment Leaders Conference and will be held for 12 months, indicating a strategic move to align with the company’s investment strategy.